Global Cardiac Monitoring Devices
Market Report
2025
Delivery Includes:- Market Timeline 2021 till 2033, Market Size, Revenue/Volume Share, Forecast and CAGR, Competitor Analysis, Regional Analysis, Country Analysis, Segment Analysis, Market Trends, Drivers, Opportunities, Restraints, ESG Analysis, Porters Analysis, PESTEL Analysis, Market Attractiveness, Patent Analysis, Technological Trend, SWOT Analysis, COVID-19 Analysis, Consumer Behavior Analysis, etc.
The base year for the calculation is 2024. The historical will be 2021 to 2024. The year 2025 will be estimated one while the forecasted data will be from year 2025 to 2033. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Cardiac Monitoring Devices Market Report 2025.
• The global Cardiac monitoring devices market will expand significantly by XX% CAGR between 2024 and 2031.
• North America held the major market of more than XX% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of XX% from 2024 to 2031.
• North America accounted for a share of over XX% of the global market size of USD XX million.
• Europe held a market of around XX% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of XX% from 2024 to 2031.
• Latin America's market will have more than XX% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of XX% from 2024 to 2031.
• Middle East and Africa held the major market of around XX% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of XX% from 2024 to 2031.
• According to Cognitive Market Research, ECG device is the dominant type segment for the cardiac monitoring devices market.
• According to Cognitive Market Research, the hospital is the dominant end-use segment for the cardiac monitoring devices market.
2021 | 2025 | 2033 | CAGR | |
---|---|---|---|---|
Global Market Size | 121212 | 121212 | 121212 | 121212 |
Country Market Size | 121212 | 121212 | 121212 | 121212 |
North Americ Market Size | 121212 | 121212 | 121212 | 121212 |
Europe Market Size | 121212 | 121212 | 121212 | 121212 |
Asia Pacific Market Size | 121212 | 121212 | 121212 | 121212 |
South America Market Size | 121212 | 121212 | 121212 | 121212 |
Middle East Market Size | 121212 | 121212 | 121212 | 121212 |
Africa Market Size | 121212 | 121212 | 121212 | 121212 |
Base Year | 2024 |
Historical Data Time Period | 2021-2024 |
Forecast Period | 2025-2033 |
Market Split by Type |
|
Market Split by End user |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Report scope is customizable as we have a huge database of Cardiac Monitoring Devices industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Cardiac Monitoring Devices Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Cardiovascular monitoring devices have transformed the way healthcare practitioners assess and manage cardiovascular health. These devices monitor heart activity in real-time or continuously, allowing for early detection of problems, progress tracking, and timely intervention as needed. Cardiac monitoring technology has grown greatly over time, from simple electrocardiogram (ECG) machines to complex wearable monitors and implanted devices. The emergence of cardiac monitoring technologies has benefited both healthcare providers and patients by providing convenient, non-invasive, and dependable methods of checking heart function. These devices have proven essential in the detection and treatment of a variety of cardiovascular disorders, including arrhythmias, heart failure, and coronary artery disease. With the development of technology, cardiac monitoring devices have gotten more advanced, including features like AI-driven analytics, wireless connectivity, and remote monitoring capabilities. increased patient outcomes and lower healthcare costs have resulted from these advances that have increased cardiac monitoring's accuracy, efficiency, and accessibility. Heart-related disorders may now be treated individually, detected early, and managed pro-actively due to the introduction of cardiac monitoring devices, which marks a significant advancement in cardiovascular care. Heart monitoring equipment will remain essential for advancing heart health and raising patient standards of living across the globe as long as technology is developed.
The rising incidence of cardiovascular disorders is a major driver of demand for cardiac monitoring equipment. As heart-related illnesses become increasingly widespread as a result of causes such as inactivity, bad eating habits, and an aging population, there is an increasing demand for monitoring devices that will help in their management. These devices provide continuous or intermittent monitoring of heart function, allowing healthcare practitioners to detect irregularities, comply with improvement, and intervene as needed. Thus, the increasing prevalence of cardiovascular disorders serves as a main driver for the development as well as utilization of cardiac monitoring devices. For instance, in May 2023, according to World Heart Federation(WHF), deaths from cardiovascular disease jumped globally from 12.1 million in 1990 to 20.5 million in 2021.
(Source:https://world-heart-federation.org/news/deaths-from-cardiovascular-disease-surged-60-globally-over-the-last-30-years-report/)
Furthermore, the increased emphasis on preventive healthcare boosts demand for cardiac monitoring devices. Individuals are encouraged to take a proactive approach to controlling their cardiovascular health, as the focus shifts to early identification and intervention. Cardiac monitoring devices are useful tools in this preventative care paradigm, allowing people to monitor their heart activity, identify potential problems, and seek medical help as needed. As the prevalence of CVD increases, the need for cardiac monitoring devices is projected to remain substantial encouraging more innovation and developments in the sector.
The primary obstacle to the growth of cardiac monitoring devices is the high cost of these devices and related services. While these devices offer vital benefits in terms of early identification, continuous monitoring, and improved cardiovascular disease management, they can also be costly for healthcare systems, providers, and patients alike. The initial cost needed to acquire cardiac monitoring equipment, particularly advanced versions with cutting-edge technology, can be expensive; as a result, healthcare organizations may be hesitant to invest in these devices due to budget constraints. In addition to the initial cost of purchase, cardiac monitoring systems require ongoing maintenance, testing, and servicing to ensure accurate and dependable operation. These continuing costs may build up over time, raising the total cost of operation for healthcare providers. Furthermore, for those with cardiovascular diseases, the out-of-pocket expenses of cardiac monitoring equipment and related services might be prohibitively expensive, especially if they do not have enough insurance coverage. This financial barrier may prevent patients from accessing necessary monitoring and follow-up care, affecting their health outcomes. Overall, the costs associated with cardiac monitoring equipment may serve as a significant obstacle to their widespread adoption and utilisation. Addressing these cost-related challenges through measures such as price transparency, reimbursement reform, and technological innovation aimed at lowering device costs could help alleviate this constraint and increase patient and provider access to cardiac monitoring devices.
The increasing integration of artificial intelligence (AI) and machine learning (ML) technology into cardiac monitoring devices is a significant opportunity that could drive additional growth. AI and machine learning algorithms have the potential to greatly improve cardiac monitoring device capabilities by enhancing the accuracy and efficiency of data analysis, interpretation, and decision-making. These technologies can help cardiac monitoring devices detect small variations in heart activity, identify patterns suggestive of cardiovascular diseases, and deliver actionable insights in real-time. Cardiac monitoring devices can deliver personalized monitoring and predictive analytics by integrating AI and machine learning, allowing healthcare providers to adjust treatment strategies to particular patient needs and risk profiles. For instance, The application of wearable AI technology intends to provide a mechanism that allows patients and clinicians to access and monitor cardiac activity remotely. Wearable AI technology is a perfect monitoring tool, providing real-time updates, monitoring, and evaluation. (Source:https://www.news-medical.net/health/Artificial-Intelligence-in-Cardiology.aspx). Furthermore, AI-powered algorithms can help optimise resource allocation, accelerate workflow processes, and lower healthcare costs related with cardiac care. The combination of AI and machine learning technology offers a potential chance to transform cardiac monitoring and change the way cardiovascular diseases are handled and treated. As these technologies evolve and mature, they are projected to promote innovation and accelerate the growth of cardiac monitoring devices, ultimately improving patient outcomes and improving the practice of cardiology.
The outbreak of the COVID-19 pandemic had a negative impact on the cardiac monitoring companies initially. Many medical treatments were suspended and only used in critical and emergency situations in order to reduce the danger of COVID-19 infection. The global lockdown impacted the supply chain for pharmaceuticals, medical equipment, and biotechnology items. However, when the number of COVID-19 cases began to diminish, research and development became increasingly important. Government agencies and healthcare providers stepped forward to help develop COVID-19 tests and treatments. For instance, in 2020, The FDA has granted Philips 510(k) clearance for its wearable biosensor, the Philips Biosensor BX100, which will help hospitals manage COVID-19 patients. The biosensor improves clinical surveillance in Philips' patient deterioration detection service, allowing physicians to identify risks and intervene early. The biosensor is programmed to collect, store, measure, and transmit respiratory and heart rates every minute, as well as surroundings including posture, activity level, and mobility.
(Source:https://www.philips.com/a-w/about/news/archive/standard/news/press/2020/20200526-philips-launches-next-generation-wearable-biosensor-for-early-patient-deterioration-detection-including-clinical-surveillance-for-covid-19.html)
We have various report editions of Cardiac Monitoring Devices Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Key players deploy strategic initiatives such as new development, product standards, and supply chain management to increase their market share. With ongoing innovation and technological advancements, heart monitoring devices are safer and more efficient than before, which has raised the acceptance of these devices. For instance, in 2021, Abbott introduced the Jot Dx, a new insertable cardiac monitor, in the U.S. The device allows remote detection and improved diagnosis of cardiac arrhythmia, reducing data burden and improving patient interaction. It connects to the myMerlin mobile app, reducing monthly data review time. The device also offers SyncUP™ support service for patient education.
(Source:https://abbott.mediaroom.com/2021-07-29-Abbott-Introduces-Jot-Dx-Insertable-Cardiac-Monitor-Designed-to-Reduce-Data-Burden-and-Improve-Accurate-Diagnosis-of-Difficult-to-Detect-Abnormal-Heart-Rhythms)
Top Companies Market Share in Cardiac Monitoring Devices Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
According to Cognitive Market Research, North America dominated the market in 2024 and accounted for around XX% of the global revenue. North America’s strong healthcare infrastructure, advanced medical facilities, and high healthcare spending make it a dominant market for cardiac monitoring devices. The country's large patient population and high prevalence of cardiovascular illness also drive demand for accurate monitoring and management. Major healthcare technology organizations and research institutions in North America stimulate innovation in cardiac monitoring devices, including wearable monitors, implantable devices, and remote monitoring systems. Overall, North America's strong healthcare infrastructure, high illness prevalence, innovation-driven sector, and supportive regulatory framework position it as the dominating market for cardiac monitoring devices.
The current report Scope analyzes Cardiac Monitoring Devices Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Global Cardiac Monitoring Devices Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Cardiac Monitoring Devices Industry growth. Cardiac Monitoring Devices market has been segmented with the help of its Type, End user , and others. Cardiac Monitoring Devices market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
According to Cognitive Market Research, the market is bifurcated into ECG devices, implantable loop recorders, mobile cardiac telemetry devices, cardiac output monitoring devices, event monitors, and Others. The segment ECG devices dominate the largest market share of XX% during the forecast period. In the field of cardiology, the ECG has long been considered an essential component of equipment due to its dependable and efficient technique for evaluating cardiac health over time and growing acceptance among medical practitioners all over the world. Furthermore, ECG is preferred for its non-invasive nature. Unlike intrusive treatments that can be risky and uncomfortable for patients, ECG simply involves attaching electrodes to the skin and recording the electrical activity of the heart. This means that it is well tolerated by patients of all ages and can be used for repeated or continuous monitoring without causing substantial discomfort or risk. Additionally, ECG provides a cost-effective method for heart monitoring inside the healthcare system. Its inexpensive cost when compared to other imaging modalities makes it available to a larger patient population. This low cost enables healthcare professionals to incorporate ECG into routine screening protocols and diagnostic workflows, aiding in the early detection and management of heart problems. Overall, ECG's continued dominance in the product type segment of cardiac monitoring devices can be due to its shown efficacy, adaptability, non-invasiveness, and cost-effectiveness. These characteristics continue to establish ECG as a core technique in the area of cardiology, resulting in widespread adoption and use in a variety of clinical situations.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Cardiac Monitoring Devices Industry. Request a Free Sample PDF!
According to Cognitive Market Research, the market is bifurcated into hospitals, clinics, cardiac centers, ambulatory surgery centers, and Others. The hospital-type segment has a significant market share since hospitals are key centers for detecting and treating various cardiovascular problems. They include specialized cardiac departments that are equipped with cutting-edge diagnostic technology, including cardiac monitoring devices, to provide complete care to patients. Furthermore, hospitals serve a broad patient population with varying cardiac health requirements. They treat patients with acute cardiac diseases that require rapid monitoring and intervention, as well as those with chronic heart conditions that require long-term monitoring and care. As a result, hospitals require a variety of cardiac monitoring technologies to properly satisfy their patients' different needs. Moreover, hospitals have the infrastructure and resources to help integrate cardiac monitoring devices into their healthcare delivery systems. They can invest in modern monitoring technology, put in place quality assurance systems, and give staff training to guarantee that cardiac monitoring devices are used efficiently and accurately. Overall, hospitals serve as important centres for cardiac care, hence they are the primary consumers of cardiac monitoring equipment. Their involvement in diagnosing, treating, and managing cardiovascular problems highlights the significance of cardiac monitoring devices in enabling timely treatments, improving patient outcomes, and reducing the burden of heart disease.
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Research Associate at Cognitive Market Research
I am Aarti Bagekari, worked as a research associate with strong passion for transforming complex information into strategic insights. My strong analytical skills, coupled with a deep understanding of market dynamics and consumer behavior, empower me to identify hidden opportunities and proactively mitigate risks for clients. As a part of team, I possess a skills in data analysis, segmentation, competitive landscape.
I am Aarti Bagekari, worked as a research associate with strong passion for transforming complex information into strategic insights. My strong analytical skills, coupled with a deep understanding of market dynamics and consumer behavior, empower me to identify hidden opportunities and proactively mitigate risks for clients. As a part of team, I possess a skills in data analysis, segmentation, competitive landscape.
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Cardiac Monitoring Devices Market is witnessing significant growth in the near future.
In 2023, the ECG devices segment accounted for noticeable share of global Cardiac Monitoring Devices Market and is projected to experience significant growth in the near future.
The Hospitals segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Progetti Srl , Narang Medical Limited and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Disclaimer:
Type | ECG devices, implantable loop recorders, mobile cardiac telemetry devices, cardiac output monitoring devices, event monitors, and Others. |
End user | Hospitals, Clinics, cardiac centers, ambulatory surgery centers, and Others. |
List of Competitors | Progetti Srl, MeTrax GmbH, Narang Medical Limited, Bexen Cardio, Amiitalia, Alivecor, Inc., OSYPKA, Shree Pacetronix, Lepu Medical Technology, Shenzhen Mindray Bio-Medical Electronics, ACS Diagnostics, BPL Medical Technologies, BioTelemetry, SCHILLER AG, Nihon Kohden, Hill-Rom Holdings, MicroPort Scientific Corporation, Asahi Kasei Corporation, Koninklijke Philips, BIOTRONIK, GE Healthcare, Abbott Laboratories, Boston Scientific, Medtronic |
This chapter will help you gain GLOBAL Market Analysis of Cardiac Monitoring Devices. Further deep in this chapter, you will be able to review Global Cardiac Monitoring Devices Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Cardiac Monitoring Devices. Further deep in this chapter, you will be able to review North America Cardiac Monitoring Devices Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Cardiac Monitoring Devices. Further deep in this chapter, you will be able to review Europe Cardiac Monitoring Devices Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Cardiac Monitoring Devices. Further deep in this chapter, you will be able to review Asia Pacific Cardiac Monitoring Devices Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Cardiac Monitoring Devices. Further deep in this chapter, you will be able to review South America Cardiac Monitoring Devices Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
This chapter will help you gain Middle East Market Analysis of Cardiac Monitoring Devices. Further deep in this chapter, you will be able to review Middle East Cardiac Monitoring Devices Market Split by various segments and Country Split.
Chapter 6 Middle East Market Analysis
This chapter will help you gain Middle East Market Analysis of Cardiac Monitoring Devices. Further deep in this chapter, you will be able to review Middle East Cardiac Monitoring Devices Market Split by various segments and Country Split.
Chapter 7 Africa Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Cardiac Monitoring Devices. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
Segmentation Type Analysis 2019 -2031, will provide market size split by Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Type Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by End user Analysis 2021 - 2033
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Cardiac Monitoring Devices market
Chapter 12 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Chapter 13 Research Methodology and Sources
Why ECG devices have a significant impact on Cardiac Monitoring Devices market? |
What are the key factors affecting the ECG devices and implantable loop recorders of Cardiac Monitoring Devices Market? |
What is the CAGR/Growth Rate of Hospitals during the forecast period? |
By type, which segment accounted for largest share of the global Cardiac Monitoring Devices Market? |
Which region is expected to dominate the global Cardiac Monitoring Devices Market within the forecast period? |